Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7338 p233
26 February 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Workforce
· The Society (2)
· Statutory Committee (3)
· Council election
· Overseas pharmacists
· The profession (2)


Letters to the Editor

The Society

Regulations will have to be challenged in courts (Mr G. Southall-Edwards)

Why such expenditure on the Council chamber? (Mr J. E. Blake)

Regulations will have to be challenged in courts

From Mr G. Southall-Edwards, MRPharmS

I should like to add my support to all those who, like David Roberts (PJ, 29 January, p112), join issue with the “non-practising” declaration that the Royal Pharmaceutical Society is requiring persons in his position to sign, if they do not wish to remain registered as “practising”. In my opinion, the Society is seeking to restrict the right of the person to disseminate what I would call “the knowledge within their mind”.

The Society should be content to require those registering as “NP” to restrict their activities to areas outside those where the law requires (or has long required) that the person be a registered pharmacist. In other words, to use David Roberts’s phrase, “preparing and dispensing medicines”, usually in accordance with the order of a duly qualified medical practitioner, in the way that pharmacists have long regarded themselves as practising their profession.

In my opinion, a person “practises” his profession when he or she does an act which, but for their registration as a practitioner in that profession, the law does not permit them to do. Restrictions which seek to go beyond this point are, I believe, none other than restrictive practices and impinge upon the personal liberty of individuals and (possibly) on their human rights.

I would also endorse other writers’ views that the Society is seeking to reach too far: it is the regulatory body for Great Britain only. Those who practise elsewhere in the EU do so by virtue of registration in the appropriate EU country, as I do. Not only should the Society therefore confine its activities to the EU (as Heather Elliston suggests, ibid, p113), but it should confine them to Britain.

I venture to suggest that sooner or later theses regulations will have to be challenged in the courts; I predict that the Society will fail to uphold its present definitions, in just the same way as it failed against Boots in its attempts to restrict self-service in 1952 — see PSGB v Boots Cash Chemists (Southern) Ltd, [1953] 1 QB 401. The problem, as it often is with the Society’s rules, is that it lays down rules that it probably cannot maintain at law, but the members are either unable or unwilling to challenge them; resigning or “renaming” oneself is not the answer. The answer lies in collective action to determine what the Society can and cannot legitimately do.

G. Southall-Edwards
Barrister-at-Law
Tirol, Austria


Why such expenditure on the Council chamber?

From Mr J. E. Blake, MRPharmS

I decided to give the Royal Pharmaceutical Society’s Council one more year before I chose to resign in protest at the huge increase in retention fees, CPD (Compulsory Pharmacist Detention — well we do have to record all the details after a hard day in the dispensary) and all the other contentious policy matters that seem to have distanced our Council from the rank and file members. But, just into the new year, we have yet another decision to spend members’ money, unwisely in my view (PJ, 12 February, p182).

Any other organisation with due regard to its costings and needs would have looked twice at any suggestion to involve itself in so much expenditure on its Council chamber. I appreciate the need to accommodate six more members of Council at its meetings. Would not an extension to the table and the purchase of six more chairs to match the existing ones be adequate? To consider even the cheapest option available will involve the use of an expensive architect. (Does the Society not know that some other professions charge a lot more per hour than the average pharmacist locum rate?) And does it really need the Council chamber to be gutted and fitted with new modular furniture? The third option of developing the first floor suite into a conference facility is beyond comprehension.

Sorry, Royal Pharmaceutical Society! There will be another resignation next year to add to the many already received.

John Blake
Caleta de Velez, Malaga, Spain

 

BERNARD KELLY, director of resources, Royal Pharmaceutical Society, replies:

As Mr Blake acknowledges, the Society’s new Council will see the addition of six members. The existing Council Chamber, built in the mid 1970s, has served the Society well for almost 30 years but simply does not have the flexibility or capacity to meet the organisation’s changing needs. The Society will commission an architect, who will draw up options for the Council to consider.

Send your letter to The Editor

Previous Topic (Workforce)
Next Topic (Statutory Committee)

Back to Top


©The Pharmaceutical Journal